Drug Profile
ATP 087
Alternative Names: ATP087Latest Information Update: 28 Mar 2021
Price :
$50
*
At a glance
- Originator Kao Corporation
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 28 Mar 2021 No recent reports of development identified for clinical-Phase-Unknown development in Atopic-dermatitis in Japan (Topical, Cream)
- 10 Feb 2018 Clinical trials in Atopic dermatitis in Japan (Topical) (UMIN000031190)